Plain-English summaries of the RCTs and meta-analyses behind our supplement recommendations. Every finding linked to the original publication.
A 2023 meta-analysis of 22 RCTs found creatine supplementation produced a statistically significant increase in 1-rep max strength (+8.1%, 95% CI: 5.4–10.9%) and lean mass (+1.37kg, 95% CI: 0.97–1.78kg) over 4–16 weeks compared to placebo. The magnitude of effect was consistent across training experience levels.
A landmark 2018 BJSM meta-analysis (Morton et al.) of 49 RCTs involving 1,863 participants found protein supplementation significantly augmented muscle mass and strength gains during resistance training. Effect size was moderate and consistent. The benefits of protein supplementation plateaued at approximately 1.62g/kg/day — additional protein above this threshold provided no further muscle-building benefit.
A 2012 double-blind, placebo-controlled RCT by Chandrasekhar et al. enrolled 64 adults with chronic stress and randomised them to 300mg KSM-66 ashwagandha twice daily or placebo for 60 days. The ashwagandha group showed a 27.9% reduction in serum cortisol and a 69% reduction in anxiety and stress scale scores vs placebo. Sleep quality also improved significantly.
A 2010 crossover RCT by Pérez-Guisado and Jakeman tested 8g citrulline malate vs placebo in resistance-trained males completing barbell bench press to failure across multiple sets. The citrulline group completed 52.92% more reps (p<0.001), reported lower post-exercise muscle soreness (40% reduction), and had higher lactate levels post-exercise indicating greater total work output.
A comprehensive 2006 meta-analysis by Buscemi et al. analysed 19 RCTs of melatonin supplementation. Key finding: melatonin significantly reduced sleep onset latency by 7–12 minutes and improved overall sleep quality. Critically, doses above 0.5–1mg produced no additional benefit over lower doses — a finding systematically ignored by the supplement industry which sells 5–10mg products.
A 2020 meta-analysis of 15 RCTs investigated omega-3 supplementation effects on exercise-induced muscle damage markers. EPA+DHA supplementation significantly reduced CK (creatine kinase, a muscle damage marker) by 25–35% post-exercise, reduced IL-6 (inflammatory cytokine) levels, and decreased delayed-onset muscle soreness (DOMS) ratings by approximately 20% compared to placebo.